Endogena

San Francisco, United States

Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.

$21.0M raised

Dec 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Endogena raised?

Endogena has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Who are Endogena's investors?

Endogena's investors include DEFTA Partners, Centenara Labs.

Where is Endogena headquartered?

Endogena is headquartered in San Francisco, United States.

What does Endogena do?

Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.

What stage is Endogena at?

Endogena is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 13, 2021.

MLA

"Endogena — Funding & Investors." VCBacked, December 13, 2021, https://www.vcbacked.co/company/endogena. Accessed July 4, 2026.

APA

VCBacked. (2021). Endogena — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/endogena

Wikipedia (cite web)

{{cite web |title=Endogena — Funding & Investors |url=https://www.vcbacked.co/company/endogena |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 13, 2021.